HomeBIOTECHNOLOGY
BIOTECHNOLOGY
Medical Device News Magazine reports breaking biotechnology news in addition to medical device news.
Fibralign Announces Strategic Partnership With Terumo
This agreement is an outcome of an ongoing collaboration between Fibralign and Terumo where the two companies have agreed to partner in efforts to commercialize BioBridge in Japan.
Plasma Therapy Accelerator – ‘SARS-Hunter” a New Solution for Better Antibody Therapy for All COVID-19 Patients
SARS-Hunter gives the possibility to hospitals to isolate the antibodies from plasma to be given as therapy and increases the chances of success of treatment, while reducing the side effects of plasma therapy given today.
Shuwen Announces Peer-Reviewed Publication of Data Demonstrating the Potential of its Breakthrough Preeclampsia Detection Device in Unselected Women
The paper, entitled “Late pregnancy screening for preeclampsia with a urinary point-of-care test for misfolded proteins”, was written by collaborators from China Medical University's Shengjing Hospital and Columbia University Medical Center in New York and demonstrates the ability of the test to detect preeclampsia at a high level of accuracy in women admitted to the hospital for any reason. The findings included over 1,500 women and were published in the peer-reviewed journal PLOS One.
SOLIUS White Paper Released: Explores Potential Impact of Vitamin D On COVID-19
The SOLIUS technology stimulates the production of vitamin D in the skin using a narrow spectrum of ultraviolet B (UVB) light.
Advanced Biological Laboratories Receives CE-IVD Registration for its SANGER and for its NGS DeepChek®-HIV Genotyping Drug Resistance Assays
Intended to be used on HIV-1 Group M viruses from patients diagnosed with HIV infection, the assays deliver standardized, open and flexible solution suited to clinical settings performing sequencing through Capillary Electrophoresis and Next Generation Sequencing (NGS) systems.
Everlywell Announces COVID-19 Test Home Collection Kit receives 1st FDA EUA of its Kind
Everlywell's EUA is the first to be issued to a digital health company such as Everlywell, which connects people and organizations with laboratory testing and is not a laboratory or diagnostics manufacturer.
Multinational Research Team Granted Eight Million Euros to Help Reduce Burden of Parasitic Disease in African Countries
The research team has just secured a grant of eight million Euros from the European & Developing Countries Clinical Trials Partnership a program supported by the European Union*. Part of this will be used to evaluate the immune status of people suffering from a disfiguring type of leishmaniasis, caused by a tiny single-celled parasite. Leishmaniasis primarily affects people in South America, East Africa and Asia, especially those weakened by malnutrition and poverty.
Mologic and BioSure partner on COVID-19 Antibody Self-Test
By combining Mologic’s independently verified COVID-19 lateral flow test with BioSure’s market-leading design, the companies have created a self-test for COVID-19 that can be used without any training being required.
Multiplex Real-Time PCR Assay for SARS-CoV-2 (Coronavirus) Pathogen Detection Launched by Eurofins Technologies
Particularly in the early phase of COVID-19 infection, the direct and precise diagnostic of the pathogen is key. PCR is the method of choice to detect acute coronavirus infections.